Logo-bi
Editorial

1. Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Mohammad Hossein Somi* ORCID
Bioimpacts. 2019;9(3): 123-127. doi: 10.15171/bi.2019.16
PMCID: PMC6726747     PMID: 31508327     Scopus ID: 85071177336    
Article
PDF
Full Text
XML
Cited By:
3
0
3
Original Research

2. PEGylated gold nanoparticles-ribonuclease induced oxidative stress and apoptosis in colorectal cancer cells
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Jaleh Barar ORCID, Hamed Farzi-Khajeh, Abolfazl Barzegari, Rahimeh Mousavi, Mohammad Hossein Somi* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(1): 27-36. doi: 10.15171/bi.2020.04
PMCID: PMC6977588     PMID: 31988854     Scopus ID: 85078959970    
Article
PDF
Full Text
XML
Cited By:
0
0
0
Original Research

3. Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer
Roya Dolatkhah ORCID, Saeed Dastgiri ORCID, Amir Taher Eftekhar Sadat, Faris Farassati, Marzieh Nezamdoust, Mohammad Hossein Somi* ORCID
Bioimpacts. 2020;10(5): ---.
Article
XML
Cited By:

BioImpacts, as a peer-reviewed international journal, publishes all types of papers on bench-to-bedside translational aspects of pharmaceutical and biomedical sciences. As a "Publish Free" and "Access Free" journal, BioImpacts follows a constructive peer-review process with free editing service to benefit the scientific community worldwide.